A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor

Hum Gene Ther. 1997 Jan 1;8(1):111-23. doi: 10.1089/hum.1997.8.1-111.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Genetic Engineering
  • Granulocyte-Macrophage Colony-Stimulating Factor / metabolism*
  • Humans
  • Immunotherapy / methods
  • Melanoma / metabolism
  • Melanoma / therapy*
  • Patient Selection
  • Statistics as Topic
  • Tumor Cells, Cultured
  • Vaccination*

Substances

  • Granulocyte-Macrophage Colony-Stimulating Factor